Factor VIIa inhibitors (AstraZeneca)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameFactor VIIa inhibitors (AstraZeneca)
Drug Alias NameAR-H044178AR-H065180AR-H065433
ClassificationSmall molecules
Mechanisms of ActionCoagulation factor VII inhibitors
TargetsCoagulation factor VII
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAstrazeneca Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAstrazeneca Plc
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A